Wave Life Sciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $-7,676 | $19,692 | $12,538 | $29,056 |
Gross Profit | -7,676 | -20,701 | 10,361 | 26,874 |
EBITDA | -61,757 | -32,825 | -32,281 | -16,500 |
EBIT | -63,915 | -34,997 | -34,458 | -18,682 |
Net Income | -61,780 | -32,923 | -31,558 | -16,256 |
Net Change In Cash | -7,676 | 19,692 | 12,538 | 29,056 |
Free Cash Flow | -46,861 | -27,520 | -33,849 | -33,412 |
Cash | 310,948 | 153,958 | 180,922 | 200,351 |
Basic Shares | 132,563 | 129,527 | 129,271 | 109,627 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $113,305 | $3,649 | $40,964 | $20,077 |
Gross Profit | 104,099 | 3,649 | -80,911 | -104,088 |
EBITDA | -58,790 | -152,606 | -117,181 | -143,394 |
EBIT | -67,996 | -162,720 | -127,016 | -153,377 |
Net Income | -57,513 | -161,823 | -122,245 | -149,910 |
Net Change In Cash | 113,305 | 3,649 | 40,964 | 20,077 |
Cost of Revenue | -61,848 | -33,725 | 37,218 | |
Free Cash Flow | -20,546 | -129,142 | -89,553 | -117,320 |
Cash | 200,351 | 88,497 | 150,564 | 184,497 |
Basic Shares | 106,097 | 78,855 | 51,825 | 39,227 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.46 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.24 |
2023-12-31 | -$0.15 |
